These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16214121)

  • 41. Screening for cytochrome P450 expression in Pichia pastoris whole cells by P450-carbon monoxide complex determination.
    Gudiminchi RK; Geier M; Glieder A; Camattari A
    Biotechnol J; 2013 Jan; 8(1):146-52. PubMed ID: 23070983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The modulation of the phenotype of the human hepatoblastoma cell line HepG2 under the action of dimethyl sulfoxide].
    Kuprina NI; Savushkina NK; Andreev AV; Gleĭberman AS
    Ontogenez; 1993; 24(4):57-67. PubMed ID: 7690467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
    Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of Human Cytochrome P450 2D6 Polymorphism on Progesterone Hydroxylation.
    Niwa T; Sasaki S; Yamamoto Y; Tanaka M
    Eur J Drug Metab Pharmacokinet; 2022 Sep; 47(5):741-747. PubMed ID: 35838883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Yeast expressed cytochrome P450 2D6 (CYP2D6) exposed on the external face of plasma membrane is functionally competent.
    Loeper J; Louérat-Oriou B; Duport C; Pompon D
    Mol Pharmacol; 1998 Jul; 54(1):8-13. PubMed ID: 9658184
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Only truncated, not complete cytochrome p450 2D6 RNA transcript and no detectable enzyme activity are expressed in human lymphocytes.
    McConnachie LA; Phillips B; Bajpai M; Shen DD; Ho RJ
    Drug Metab Dispos; 2003 Sep; 31(9):1103-7. PubMed ID: 12920165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [CYP2D6*1, CYP2D6*10 co-expressed with CYPOR in Bac-to-Bac expression system and activity determination].
    Qian MR; Chen J; Liu Y; Yu LS; Chen SQ; Zeng S
    Yao Xue Xue Bao; 2011 Feb; 46(2):207-12. PubMed ID: 21542294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The importance of heterogeneous nuclear ribonucleoprotein K on cytochrome P450 2D2 gene regulation: its binding is reduced in Dark Agouti rats.
    Sakai N; Sakamoto KQ; Fujita S; Ishizuka M
    Drug Metab Dispos; 2009 Aug; 37(8):1703-10. PubMed ID: 19420131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of genetic variation on human cytochrome p450 reductase-mediated paraquat cytotoxicity.
    Han JF; Wang SL; He XY; Liu CY; Hong JY
    Toxicol Sci; 2006 May; 91(1):42-8. PubMed ID: 16495354
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutagenic activation of betel quid-specific N-nitrosamines catalyzed by human cytochrome P450 coexpressed with NADPH-cytochrome P450 reductase in Salmonella typhimurium YG7108.
    Miyazaki M; Sugawara E; Yoshimura T; Yamazaki H; Kamataki T
    Mutat Res; 2005 Mar; 581(1-2):165-71. PubMed ID: 15725615
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy.
    Bonifacio A; Keizers PH; Commandeur JN; Vermeulen NP; Robert B; Gooijer C; van der Zwan G
    Biochem Biophys Res Commun; 2006 May; 343(3):772-9. PubMed ID: 16563352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional expression in Bacillus subtilis of mammalian NADPH-cytochrome P450 oxidoreductase and its spore-display.
    Yim SK; Jung HC; Yun CH; Pan JG
    Protein Expr Purif; 2009 Jan; 63(1):5-11. PubMed ID: 18678259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of genetic variants of human P450 oxidoreductase on catalysis by CYP2D6 in vitro.
    Sandee D; Morrissey K; Agrawal V; Tam HK; Kramer MA; Tracy TS; Giacomini KM; Miller WL
    Pharmacogenet Genomics; 2010 Nov; 20(11):677-86. PubMed ID: 20940534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Optimization of an in vivo plant P450 monooxygenase system in Saccharomyces cerevisiae.
    Jiang H; Morgan JA
    Biotechnol Bioeng; 2004 Jan; 85(2):130-7. PubMed ID: 14704995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of genetic polymorphism on the metabolism of endogenous neuroactive substances, progesterone and p-tyramine, catalyzed by CYP2D6.
    Niwa T; Hiroi T; Tsuzuki D; Yamamoto S; Narimatsu S; Fukuda T; Azuma J; Funae Y
    Brain Res Mol Brain Res; 2004 Oct; 129(1-2):117-23. PubMed ID: 15469888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Propranolol hydroxylation and N-desisopropylation by cytochrome P4502D6: studies using the yeast-expressed enzyme and NADPH/O2 and cumene hydroperoxide-supported reactions.
    Bichara N; Ching MS; Blake CL; Ghabrial H; Smallwood RA
    Drug Metab Dispos; 1996 Jan; 24(1):112-8. PubMed ID: 8825198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Application of HC-AFW1 Hepatocarcinoma Cells for Mechanistic Studies: Regulation of Cytochrome P450 2B6 Expression by Dimethyl Sulfoxide and Early Growth Response 1.
    Petzuch B; Groll N; Schwarz M; Braeuning A
    Drug Metab Dispos; 2015 Nov; 43(11):1727-33. PubMed ID: 26307675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of cytochrome P450-reductase as the enzyme responsible for NADPH-dependent lucigenin and tetrazolium salt reduction in rat epididymal sperm preparations.
    Baker MA; Krutskikh A; Curry BJ; McLaughlin EA; Aitken RJ
    Biol Reprod; 2004 Jul; 71(1):307-18. PubMed ID: 15031143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Kemp CA; Flanagan JU; van Eldik AJ; Maréchal JD; Wolf CR; Roberts GC; Paine MJ; Sutcliffe MJ
    J Med Chem; 2004 Oct; 47(22):5340-6. PubMed ID: 15481972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CYP2D6 increases toxicity of the designer drug 4-methylthioamphetamine (4-MTA).
    Carmo H; Brulport M; Hermes M; Oesch F; de Boer D; Remião F; Carvalho F; Schön MR; Krebsfaenger N; Doehmer J; Bastos Mde L; Hengstler JG
    Toxicology; 2007 Jan; 229(3):236-44. PubMed ID: 17156908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.